###begin article-title 0
###xml 39 44 <span type="species:ncbi:9606">human</span>
Members of the SRY family regulate the human LINE retrotransposons
###end article-title 0
###begin p 1
To whom correspondence should be addressed. Tel: +33 1 42 11 49 70; Fax: +33 1 42 11 53 42; Email: heidmann@igr.fr
###end p 1
###begin p 2
###xml 185 190 <span type="species:ncbi:9606">human</span>
LINEs are endogenous mobile genetic elements which have dispersed and accumulated in the genomes of most higher eukaryotes via germline transposition, with up to 100 000 copies for the human LINE-1 (L1H) sequences. Although severely repressed in most normal tissues, L1H is still functional, with evidence for both germline and somatic-essentially in tumors-transpositions. Yet, no transcription factor that could regulate their transcription and be responsible for their transposition has hitherto been described. Here we show that factors belonging to the family of the testis-determining factor gene SRY (the SOX family) can modulate L1H promoter activity over a 10-fold range in a transient transfection assay using a luciferase reporter gene. These effects depend on two functional SRY binding sites which can be identified within the L1H promoter via mobility shift assays. Induction of endogenous L1Hs upon ectopic expression of the SOX11 transcription factor is further demonstrated, thus strengthening the physiological relevance of these new-and highly dispersed-target sites for the otherwise unclassical transcription factors of the SRY family.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 174 175 174 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c1">1</xref>
###xml 448 449 448 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c2">2</xref>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c3">3</xref>
###xml 609 610 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c4">4</xref>
###xml 611 612 611 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c6">6</xref>
###xml 632 633 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c7">7</xref>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c8">8</xref>
###xml 661 662 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c9">9</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c10">10</xref>
###xml 963 965 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c11">11</xref>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c12">12</xref>
###xml 1007 1009 1007 1009 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c13">13</xref>
###xml 1092 1094 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c11">11</xref>
###xml 1095 1097 1095 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c12">12</xref>
###xml 1227 1229 1227 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c13">13</xref>
###xml 1420 1422 1420 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c13">13</xref>
###xml 1526 1528 1526 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c14">14</xref>
###xml 1572 1574 1572 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c15">15</xref>
###xml 1698 1700 1698 1700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c16">16</xref>
###xml 73 78 <span type="species:ncbi:9606">human</span>
###xml 333 338 <span type="species:ncbi:9606">Human</span>
###xml 2081 2086 <span type="species:ncbi:9606">human</span>
LINEs are highly reiterated transposable elements (100 000 copies in the human genome), responsible for several genetic diseases through insertional mutagenesis (reviewed in 1). Their transposition requires synthesis of a full-length genomic RNA (gRNA) followed by its reverse transcription and integration by LINE-encoded proteins. Human LINE-1 (L1H) transcription is driven by an internal promoter located within the first 670 bp of the element (2,3). It is severely repressed in most somatic, differentiated cells, but induction can be observed in embryonal carcinoma cells and testicular germline tumors (4-6). DNA methylation (7,8) and RNA polymerase III (9,10) have been tentatively identified as playing a role in L1H promoter activity, but no transcription factor that could regulate transcription of endogenous L1Hs has been described. We show here that the L1H promoter contains two functional binding sites for transcription factors of the SRY family (11,12), namely the SOX factors (reviewed in 13). SRY, the prototype of the SOX family members, is involved in sex determination (11,12). It is expressed in the urogenital ridge of the embryo and, in the adult, in the testis, hypothalamus and midbrain (reviewed in 13). Although less extensively studied, other SOX factors also appear to be expressed according to restricted and specific patterns, mainly during development and, in some cases, in the adult (13). SOX factors all share a conserved domain of about 80 amino acids, the High Mobility Group (HMG) box (14)-also found in the HMG1 and HMG2 proteins (15). This HMG box is involved in DNA binding and a consensus sequence for SOX binding sites has been derived as A/TA/TCAAA/T (16 and references therein). The two binding sites that we presently identify in the L1H promoter are functional sites, which are required for some of the SOX members to transactivate a luciferase reporter gene driven by the L1H promoter. Ectopic overexpression of one member of the SRY family, SOX11, is further shown to result in a 10-fold transactivation of the endogenous L1Hs in human cells.
###end p 4
###begin title 5
MATERIALS AND METHODS
###end title 5
###begin title 6
Cell culture and transfection
###end title 6
###begin p 7
###xml 230 231 224 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 753 758 737 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX11</italic>
###xml 799 802 783 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 180 184 <span type="species:ncbi:9913">calf</span>
RD and 293 cells (from the European Collection of Cell Cultures) and NTera2/D1 (from the ATCC) were grown in DMEM-in MEM for 293 cells-supplemented with 4.5 g/l glucose, 10% fetal calf serum and antibiotics, at 37degreesC in 6% CO2. Transfections of dispersed cells were carried out with Lipofectamine Plus Reagent (Gibco BRL) or Geneporter (Boehringer Mannheim) according to manufacturers' instructions. Cells were harvested 2 days post-transfection for transient transfection assays. Luciferase activity was measured with a luciferase assay kit (Promega) and beta-galactosidase activity with CPRG (Boehringer Mannheim) as a beta-galactosidase substrate, using the same cell extract. For stable transfections, cells were cotransfected with the pJ3OmegaSOX11 vector, or control vector, and the pSVTKneobeta plasmid, conferring G418 resistance, at a 19:1 molar ratio, and G418R cell clones were isolated using 1 mg/ml G418 (Gibco BRL).
###end p 7
###begin title 8
Plasmids
###end title 8
###begin p 9
###xml 2 5 2 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 76 77 76 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c1">1</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c17">17</xref>
###xml 227 230 227 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bst</italic>
###xml 271 274 271 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 356 359 356 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 380 383 380 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 422 425 422 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 427 430 427 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bam</italic>
###xml 529 532 529 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 538 541 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bgl</italic>
###xml 824 825 824 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c2">2</xref>
###xml 855 859 855 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX3</italic>
###xml 921 925 921 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX3</italic>
###xml 957 960 957 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 1021 1024 1021 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 1054 1058 1054 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX3</italic>
###xml 1105 1110 1105 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX11</italic>
###xml 1144 1149 1140 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX11</italic>
###xml 1211 1214 1207 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 1268 1273 1260 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX11</italic>
###xml 1304 1307 1296 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX</italic>
###xml 1436 1439 1425 1428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 1342 1345 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1504 1507 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
L1luc reporter gene and mutated L1Amluc, L1Bmluc and L1AmBmluc derivatives (1). The L1H promoter was excised from pL1.2A plasmid [which contains L1.2A L1H element (17) with no flanking cellular DNA, subcloned in pGEM5Zf+] as a BstXII (position 902 in L1H) Klenow-treated SacII (in pGEM5Zf+ polylinker) fragment and subcloned in pKS- (Stratagene) opened by XbaI Klenow-treated and SacII. L1H promoter was then excised as a SacI-BamHI fragment (both sites in PKS-polylinker) and inserted into pGL3 Basic Vector (Promega) opened by SacI and BglII [both sites in the polylinker, upstream of the luciferase open reading frame (ORF)]. Mutations in the A and B sites were introduced by PCR with oligonucleotide primers carrying the modified sequences. L1H sequences for all the luciferase vectors were verified by DNA sequencing. (2) SOX expression vectors: the SOX3 sequence was excised from plasmid X2-1 H33 (which contains a SOX3 genomic fragment cloned at the HindIII site of pKS+; gift from P. Hextall, Cambridge, UK) as a HindIII (~440 bp upstream of the SOX3 ORF first AUG codon) Klenow-treated fragment. SOX11 ORF was excised from the pJ3OmegaSOX11 expression vector (gift from P. Berta, UPR1142, France) as a HindIII (located in the polylinker of pJ3Omega and 3' to SOX11 ORF) Klenow-treated fragment. SOX fragments (or no fragment for the CMV-none control expression vector) were cloned into the pCMVbeta vector (Clontech) opened by NotI (which removes the beta-galactosidase ORF) and Klenow-treated. CMV-SRY was a gift from M. Fellous (Pasteur Institute, France).
###end p 9
###begin title 10
Northern blot analysis
###end title 10
###begin p 11
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 44 45 44 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 458 459 455 456 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 667 669 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c18">18</xref>
###xml 735 736 732 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Cytosolic RNA was extracted using 107-4 x 107 cells, which were first rinsed twice with isotonic phosphate-buffered (pH 7.5) saline (PBS), and then harvested, after trysin/EDTA treatment, by soft pipetting in PBS. After centrifugation, the cells were lysed by a 10-min incubation on ice in 1 ml of EBC buffer (0.5% Nonidet P-40, 10 mM Tris-HCl pH 7.9, NaCl 140 mM) supplemented with 30 mM beta-mercaptoethanol, 5 mM ribosyl-orthovanadate complexes, 2 mM MgCl2 and brief vortexing. Supernatants recovered after a 10-min centrifugation at 13 000 r.p.m. were supplemented with 7 ml guanidium-thiocyanate and further processed by the guanidium/cesium chloride procedure (18). RNAs were separated by electrophoresis and blotted onto HybondN+ filters (Amersham) according to the manufacturer's instructions.
###end p 11
###begin p 12
###xml 75 78 75 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sac</italic>
###xml 274 276 270 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 493 496 489 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
L1H single-stranded DNA probes were synthesised by submitting 100 ng of pL1luc plasmid linearised with SacI (site just 5' to the L1H 1-906 promoter sequence) to 20 cycles of PCR using the GLprimer2 (Promega) oligonucleotide (located 65 bp 3' to the L1H promoter) and [alpha-32P]dCTP. Labelled DNA was purified by elution through a Sephadex G50 column. Control experiments disclosed that this single-strand DNA probe, but not the complementary one (generated as above after linearisation of pL1luc and PCR amplification with the Promega RVprimer3 oligonucleotide), specifically hybridised to L1H gRNA from NTera2/D1 cells.
###end p 12
###begin title 13
Electrophoretic mobility shift assay
###end title 13
###begin p 14
###xml 68 71 68 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 171 187 171 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 609 611 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c19">19</xref>
###xml 961 967 945 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 1021 1023 1005 1007 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 171 187 <span type="species:ncbi:562">Escherichia coli</span>
###xml 591 596 <span type="species:ncbi:9606">human</span>
###xml 961 967 <span type="species:ncbi:562">E.coli</span>
The indicated DNA probes were synthesised by PCR with linearised pL1luc or its mutated derivatives as templates and adequate oligonucleotide primers. Procedures to obtain Escherichia coli cytoplasmic cell extracts were as follows: lysis of the washed bacterial cells in 50 mM sodium phosphate buffer pH 7.4, 50 mM NaCl, 10 microg/ml RNase A, 1 mg/ml lyzozyme, 1 mM PMSF, 0.2% Tween, brief sonication, centrifugation at 13 000 r.p.m. for 15 min and harvesting of the supernatant. pT7-hSRYbox88 bacterial cells contains an IPTG-inducible plasmid encoding the 88 amino acid long HMG box of the human SRY factor (19). In our hand, this peptide was produced in too weak amounts to be detected upon SDS-PAGE electrophoresis and Coomassie blue staining of the bacterial cell extract. Protein-DNA binding reactions were performed in 30 microl, containing 100 mM KCl, 20% glycerol, 20 mM HEPES pH 7.9, 1 mM DTT, 1 mM EDTA, 1 mM PMSF, 1 microg salmon sperm DNA, 6 microg E.coli cytoplasmic cell extracts and ~100 000 c.p.m. of the 32P-labelled DNA probes.
###end p 14
###begin title 15
RESULTS
###end title 15
###begin p 16
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c9">9</xref>
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c17">17</xref>
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f1">1</xref>
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f1">1</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c11">11</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c12">12</xref>
###xml 552 558 552 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c19">19</xref>
###xml 774 775 774 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 784 785 784 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 851 852 851 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f1">1</xref>
###xml 552 558 <span type="species:ncbi:562">E.coli</span>
Using a computer search program (TFSEARCH version 1.3), we identified two potential binding sites for SOX transcription factors within the first 670 nt of the L1H sequence (9,17): one between nucleotides 472 and 477 (site A) and another between nucleotides 572 and 577 (site B), both with the sequence AACAAA (Fig. 1A). Electrophoretic mobility shift experiments (Fig. 1B) confirmed that these A and B sites can specifically interact with the DNA binding domain of SRY-the prototype of the SOX family members (11,12). Indeed, cytoplasmic extracts from E.coli cells expressing the SRY HMG box domain (hSRYbox88) (19), but not cytoplasmic extracts from control cells, alter the mobility of DNA probes encompassing the A or B sites. Moreover, mutations introduced into the A (Am) or B (Bm) sites abolished the observed SRY-dependent mobility shift (Fig. 1B).
###end p 16
###begin p 17
###xml 138 141 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c2">2</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c17">17</xref>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f1">1</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f2">2</xref>
###xml 513 516 513 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 644 645 638 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f2">2</xref>
###xml 910 911 904 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f2">2</xref>
###xml 932 934 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c20">20</xref>
###xml 935 937 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c21">21</xref>
###xml 960 963 954 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 1097 1099 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c22">22</xref>
###xml 1100 1102 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c23">23</xref>
###xml 1126 1129 1120 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 1204 1207 1198 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 1524 1527 1518 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 1597 1598 1591 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f2">2</xref>
###xml 1820 1822 1814 1816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c24">24</xref>
###xml 1941 1942 1935 1936 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 1951 1952 1945 1946 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 1969 1970 1963 1964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f1">1</xref>
###xml 2000 2003 1994 1997 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 2031 2032 2025 2026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f2">2</xref>
###xml 704 709 <span type="species:ncbi:9606">human</span>
###xml 738 743 <span type="species:ncbi:9606">human</span>
###xml 1177 1182 <span type="species:ncbi:9606">human</span>
###xml 1331 1335 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1681 1686 <span type="species:ncbi:9606">human</span>
These observations led us to examine whether L1H promoter-driven transcription is modulated by SOX factors. A luciferase reporter gene (L1luc) was therefore constructed by inserting the first 906 nt of L1H [corresponding to the promoter-containing 5' UTR of the L1.2A clone (2,17), Fig. 1A] into a commercially available luciferase vector (Fig. 2A and Materials and Methods). The effects of various SOX proteins on L1H promoter activity was then analysed by transient co-transfection of cultured cells with the L1luc reporter together with different SOX expression vectors and a beta-galactosidase expressing gene (pCMVbeta, see legend to Fig. 2) to normalise for transfection efficiency. Cells from the human RD cell line-derived from a human embryo rhabdomyosarcoma-were used as recipients because they display a very low basal level of endogenous L1H gRNA (T.Tchenio, unpublished). As illustrated in Figure 2B, the SOX11 factor (20,21) transactivates the L1luc reporter gene up to a maximum of 9-fold (at 200 ng DNA), followed by a small decrease at higher DNA concentrations. The SOX3 factor (22,23) also transactivates L1luc, but only to a limited extent. Conversely, the human SRY factor reduces L1luc expression by ~2-fold, under conditions where no effect of SRY on a control luciferase reporter gene driven by the minimal SV40 promoter (pGL3promoter vector; Promega) was observed (data not shown). This antagonistic effect of SRY on L1H promoter is also manifested by the observed reduction of the SOX11-mediated L1luc transactivation in the presence of SRY, not observed with SOX3 (Fig. 2C). These results are in agreement with the absence of an activation domain in the human SRY factor, and with the reported inhibitory effects of SRY on a recombinant thymidine kinase promoter flanked by SRY binding sites (24). Finally, to demonstrate the role of the A and B sites in the SOX-mediated regulation of L1H promoter activity, the Am and/or Bm mutations (Fig. 1A) were introduced into the L1luc vector. The data in Figure 2D show that both sites are required for full transactivation by the SOX11 protein and that mutation of both sites completely abolishes the SOX11 stimulatory effect.
###end p 17
###begin p 18
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c6">6</xref>
###xml 630 631 630 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f3">3</xref>
###xml 767 772 767 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX11</italic>
###xml 790 793 790 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY</italic>
###xml 907 908 907 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f3">3</xref>
###xml 1103 1108 1099 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX11</italic>
###xml 1509 1510 1505 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkd159f3">3</xref>
###xml 1822 1824 1818 1820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c25">25</xref>
###xml 178 183 <span type="species:ncbi:9606">human</span>
###xml 415 420 <span type="species:ncbi:9606">human</span>
###xml 548 554 <span type="species:ncbi:10090">murine</span>
###xml 763 766 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 786 789 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1074 1078 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
To analyse whether ectopic expression of SOX proteins can modulate the level of endogenous L1H gRNA, a transient transfection assay was performed, using the easily transfectable human kidney-derived 293 cells. Endogenous L1H RNAs were then analysed by northern blot, upon hybridisation with an antisense L1H single-stranded DNA probe (Materials and Methods). NTera2/D1 embryonal carcinoma cells-one of the only few human cell lines in which high level expression of a discrete 6 kb L1H gRNA can be detected by northern blot analysis (6)-as well as murine NIH 3T3 cells (devoid of L1H genetic elements) were used as controls (Fig. 3A). Although endogenous L1H transcripts are not highly expressed in the 293 cell line, transient transfection of the cells with the CMV-SOX11, but not the CMV-SRY, vector resulted in an increase in the accumulation level of the 6 kb L1H-hybridising transcript (2-3-fold, Fig. 3A and data not shown). To further confirm these results, stably transfected SOX-expressing cells were established. A vector expressing SOX11 under the control of the SV40 early promoter (pJ3OmegaSOX11 vector) was introduced by transfection into RD cells together with a vector for the selectable neomycin gene. G418-resistant clones were then isolated, and those expressing stably integrated SOX11 vectors (about one-third of the transfected clones) were characterised by Southern and northern blot analyses (data not shown). As illustrated for independent clones by the northern blot shown in Figure 3B, L1H gRNAs-as detected using the antisense L1H probe-were induced in the SOX11 expressing cells, ~10-fold as compared to control transfected cells. A heterogenous population of L1H-hybridising transcripts of larger size, most probably originating from inefficient transcription termination of endogenous L1Hs (25), was also induced upon SOX11 expression, resulting in the observed smear of high molecular weight RNAs. No antisense transcripts were detected in these clones using, under identical experimental conditions, a sense L1H single-stranded DNA probe (data not shown), thus indicating that the transcripts observed above do originate from L1Hs.
###end p 18
###begin title 19
DISCUSSION
###end title 19
###begin p 20
###xml 100 113 100 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sensu stricto</italic>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c26">26</xref>
###xml 638 640 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c13">13</xref>
###xml 926 928 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c13">13</xref>
###xml 929 931 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c16">16</xref>
###xml 1080 1083 1076 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink">via</italic>
###xml 1247 1249 1243 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c27">27</xref>
###xml 1250 1252 1246 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c28">28</xref>
###xml 1450 1452 1446 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c29">29</xref>
###xml 1453 1455 1449 1451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c30">30</xref>
###xml 1583 1590 1579 1586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1823 1825 1819 1821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c31">31</xref>
###xml 2033 2041 2029 2037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de facto</italic>
###xml 2562 2569 2558 2565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 2811 2813 2807 2809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkd159c32">32</xref>
###xml 2945 2952 2941 2948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 2577 2582 <span type="species:ncbi:9606">human</span>
The present results therefore show that the human L1H promoter not only contains SRY binding sites, sensu stricto, but that these sites are indeed 'functional', being responsible for the efficient transactivation of the L1H promoter by a SOX family member. Although one would expect the rather degenerate consensus SOX binding sequence (i.e. A/TA/TCAAA/T) to be frequently encountered, and despite the limited sequence specificity for SOX binding (26), functional SOX sites have been identified in only a limited number of genes (including the Mullerian Inhibiting Substance, the FGF4, the collagen II and the TCRalpha genes; reviewed in 13). It has been suggested that the much more stringent conditions required for a SOX 'effect' versus 'binding' is due in part to a recognition sequence that extends beyond the consensus sequence and/or the ability of SOX to make protein-protein contacts with other DNA binding proteins (13,16). In fact, it has been proposed that the mode of action of the SRY factor and related proteins is to organise the local chromatin structure-in part via their ability to bend DNA in a sequence-dependent manner-and assemble other DNA-bound factors into biologically active, sterically defined multiprotein complexes (27,28). In the case of L1H, no conspicuous binding site for other known transcription factors has yet been identified in the promoter sequence, except those previously characterised for the YY1 protein (29,30). Being ubiquitously expressed, it is very unlikely that YY1 accounts for the restricted pattern of L1H expression as observed in vivo, but it remains plausible that it cooperates with SOX factors to assemble the transcription machinery at the L1H promoter, all the more as YY1 is itself an 'architectural' factor which can promote DNA binding to the nuclear matrix (31). Whatever the underlying mechanisms for the SOX-mediated transactivation, a noteworthy consequence of the present investigation is that the high copy number of full-length L1H transposable elements results de facto in the dispersion of thousands of functional SOX binding sites in the genome. Targeting of SOX factors to these sites may therefore result not only in the activation of the LINE elements themselves, but also in that of nearby genes, possibly via SOX-mediated 'architectural' effects. This would constitute an unexpected and important additional consequence of transposon mobility on genome structure and gene regulation. Finally, an important issue will be to determine whether SOX factors, such as SOX11, are expressed in vivo in the human germ cell lineage, that could activate L1H elements. In fact, several SOX family members are likely to be expressed in these cells, as suggested by the demonstrated expression of various SOX factors in germline-derived tumours (32 and references therein). Such germline-expressed SOX factors would be serious candidates as essential determinants of L1H activity in vivo under both normal and pathological conditions.
###end p 20
###begin title 21
Figures and Tables
###end title 21
###begin p 22
###xml 41 42 41 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 489 490 489 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 496 497 496 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 566 567 566 567 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 729 730 729 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 736 737 736 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 803 805 803 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 869 875 869 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E.coli</italic>
###xml 869 875 <span type="species:ncbi:562">E.coli</span>
 SRY binding sites in the L1H promoter. (A) Identification of two consensus SRY binding sites in the L1H element. On top, a complete L1H element is schematised with the 5' and 3' untranslated regions (UTRs), the two open reading frames (ORF), and the transcription start site located at the first nucleotide of L1H (indicated with an arrow). The A and B sites in the L1H 5' UTR (at nucleotide positions 472 and 572) are indicated in bold capital letters, and the introduced mutations, in Am and Bm, are indicated below with mutated nucleotides in bold lower case). (B) Electrophoretic mobility shift assay for binding of the SRY HMG box peptide to the A and B sites. The DNA probes encompassing the A or B sites (or the mutated Am and Bm sequences) are shown on top with nucleotide positions indicated. 32P-labelled probes were incubated with pT7-hSRYbox88-transformed E.coli cytoplasmic extracts (SRY), control cell extracts (control) or no extract (none). The shifted bands are indicated with an arrow.
###end p 22
###begin p 23
###xml 109 110 109 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 346 347 346 347 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 419 422 419 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 455 456 455 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 559 562 559 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX</italic>
###xml 893 896 883 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 948 951 938 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 1002 1005 992 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 1058 1059 1048 1049 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 1131 1134 1121 1124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 1206 1211 1196 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX11</italic>
###xml 1278 1282 1268 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX3</italic>
###xml 1290 1293 1280 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY</italic>
###xml 1388 1389 1378 1379 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1528 1531 1518 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">luc</italic>
###xml 1569 1570 1559 1560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 1579 1580 1569 1570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">m</sup>
###xml 1630 1635 1620 1625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX11</italic>
###xml 92 97 <span type="species:ncbi:9606">human</span>
###xml 457 462 <span type="species:ncbi:9606">human</span>
###xml 555 558 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 658 661 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 854 857 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1177 1180 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1202 1205 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1264 1267 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1274 1277 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1286 1289 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1614 1617 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1626 1629 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 1705 1709 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
 Modulation of L1H promoter activity by SOX proteins in transient transfection assays using human RD cells. (A) Structure of the L1luc luciferase reporter gene. The L1H promoter sequence (L1H) from nucleotide 1 to 906 was inserted into the polylinker of pGL3 basic vector (Promega), upstream of the luciferase ORF. PolyA, polyadenylation sites. (B) Effects of varying amounts of transfected SOX expression vectors on L1luc reporter gene activity. About 106 human RD cells were cotransfected with 20 ng of luciferase reporter gene, the indicated amount of CMV-SOX expression vector, 200 ng of pCMVbeta plasmid, complemented to a total of 1 microg of DNA with CMV-none. Luciferase activity was normalised to beta-galactosidase activity measured in the same cell extracts. L1H promoter activity is expressed relative to that measured upon transfection with CMV-none set as 1 [and similarly for L1luc in (C) and (D)]. Luciferase activity for a control luc vector lacking the L1H promoter was <3% that of L1luc. Standard deviations are indicated by errors bars. (C) Interactions between SOX proteins. RD cells were cotransfected with L1luc as in (B) with 800 ng of control plasmid (CMV-none) or with 200 ng CMV-SOX11 plus 600 ng of one of the three following plasmids: CMV-none, CMV-SOX3 or CMV-SRY; n indicates the number of independent experiments, and errors bars are standard deviations. (D) Effect of mutations within the A and B sites on SOX11-mediated L1H promoter activation. RD cells were cotransfected as in (B) with the L1luc reporter gene or one of its mutated Am and/or Bm derivative, and 800 ng of either CMV-none or CMV-SOX11. pGL3 is a luciferase reporter gene under the control of the minimal SV40 promoter (Promega); n indicates the number of independent experiments, and errors bars are standard deviations.
###end p 23
###begin p 24
###xml 53 54 53 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 217 220 210 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY</italic>
###xml 234 239 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX11</italic>
###xml 793 794 780 781 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 940 945 919 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX11</italic>
###xml 213 216 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 230 233 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
 Sox11-mediated transactivation of endogenous L1Hs. (A) Northern blot analysis of transiently transfected 293 cells. RNA (15 microg per lane) extracted from cells transiently transfected with either pCMVbeta (C), CMV-SRY (SRY) or CMV-SOX11 (SOX) were electrophoresed together with NTera2/D1 (N) and NIH 3T3 (T) RNA samples, and hybridised with an antisense (nucleotide 906 to 1) L1H single-stranded DNA probe. Arrows indicate the position of L1H gRNA. The numbers indicate the relative level of L1H gRNA as normalised to the amount of 3-glyceraldehyde phosphate deshydrogenase transcripts. Exposure time was 3 days. In this experiment, the percentage of transfected cells was close to 20% as deduced from the percentage of beta-galactosidase-positive cells in the transfection with pCMVbeta. (B) Northern blot analysis of total RNA (15 microg per lane) from independent RD cell clones stably transfected with control (c1 and c2) or pJ3OmegaSOX11 expression vector (s1, s2), using the same antisense single-stranded DNA probe as in (A). Exposure time was 1 and 3 days for NTera2/D1 and RD cells, respectively. Control hybridisation with a beta-actin probe is shown (exposure time 16 h).
###end p 24
###begin title 25
ACKNOWLEDGEMENTS
###end title 25
###begin p 26
###xml 38 43 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SOX11</italic>
###xml 68 71 64 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SRY</italic>
###xml 64 67 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
We thank P. Berta for plasmid pJ3OmegaSOX11, M. Fellous for the CMV-SRY expression vector, P. Hextall for plasmid X2-1 H33 and the pT7-hSRYbox88 containing bacterial strain, and H. H. Kazazian for the cloned L12.A element. P. Berta is also acknowledged for helpful suggestions, S. Cristescu and C. Lavialle for critical reading of the manuscript.
###end p 26
###begin title 27
REFERENCES
###end title 27

